Senior Staff Physician Director, Transplant Infectious Diseases , Medical Director of Infection Prevention, Henry Ford Hospital; Professor of Medicine, Wayne State University
BIOGRAPHY
MAY 22, 2017 10:00 AM PDT
WEBINAR: The clinical impact and implementation of T2MR and the T2Candida Panel in the management of candidemia at a large tertiary care health system
Speaker
Event Date & Time
DATE: May 22, 2017
TIME: 10:00am PT, 1:00pm ET
Abstract
Learn from renowned clinical expert, George J. Alangaden, M.D., as he discusses how Henry Ford Health System (HFHS) implemented T2MR and the T2Candida Panel as part of their sepsis protocol for the management of candidemia. Dr. Alangaden will also share the positive impact T2MR and T2Candida has had at HFHS on patient length of stay and antifungal use.
Learning Objectives:
- Understand the process for implementation of T2MR and the T2Candida Panel at the Henry Ford Health System (HFHS)
- Understand the impact of T2Candida Panel on the management of patients with candidemia at HFHS
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
MAY 22, 2017 10:00 AM PDT
Share
WEBINAR: The clinical impact and implementation of T2MR and the T2Candida Panel in the management of candidemia at a large tertiary care health system
Loading Comments...